Treatment Dynamics in People Who Initiate Metformin or Sulfonylureas for Type 2 Diabetes: A National Cohort Study

Aim: To investigate the incidence of, and factors associated with addition and switching of glucose-lowering medications within 12-months of initiating metformin or a sulfonylurea for type 2 diabetes (T2D). Methods: We identified 109,573 individuals aged 18–99 years who initiated metformin or a sulf...

Descripción completa

Detalles Bibliográficos
Autores principales: Wood, Stephen, Magliano, Dianna J., Bell, J Simon, Shaw, Jonathan E., Ilomäki, Jenni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712936/
https://www.ncbi.nlm.nih.gov/pubmed/34970149
http://dx.doi.org/10.3389/fphar.2021.794273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712936/
https://www.ncbi.nlm.nih.gov/pubmed/34970149
http://dx.doi.org/10.3389/fphar.2021.794273

Ejemplares similares